Bank Of Montreal Catalyst Biosciences, Inc. Transaction History

Bank Of Montreal

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$0.91 - $4.16 $183,151 - $837,262	-201,265 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$3.78 - $5.18 $42,082 - $57,668	-11,133 Reduced 5.24%	201,265 $962,000
Q2 2021 Aug 12, 2021	BUY	$4.1 - $5.33 $870,831 - $1.13 Million	212,398 New	212,398 $971,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.